Introduction
Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy or in the first postpartum year. It is the most common cause of invasive cancer in pregnant women and is estimated to occur at a rate of 6.5 per 100,000 live births [1, 2] . According to a case control study from Princess Margaret Hospital, pregnant patients are at higher risk for presenting with advanced disease because pregnancy impedes early detection [3] . Risk factors for pregnancy-associated breast cancer include early age of menarche, nulliparity, personal history of breast cancer, advanced maternal age, family history of breast cancer, increased consumption of alcohol, obesity and a sedentary lifestyle [4] . Of interest to Obstetricians is the management of breast cancer in pregnancy. The timing of delivery should take into account maternal and fetal status as well as need for further chemotherapy and expected perinatal outcome while the mode of delivery should be determined by standard obstetrical indications [5] . In an article by Trichopoulos et al., full term births over the age of 35 years had an increased risk in the development of breast cancer; uniparous women were observed to have an elevated risk of breast cancer soon after delivery, specifically those women who are 30 years or older at the time of their first delivery [6] . We present a case of premenopausal invasive ductal carcinoma of the breast diagnosed during pregnancy, and review the literature regarding the antenatal management of breast cancer.
Case Description
A 29 year old multiparous Hispanic female presented to our routine obstetrical clinic at 7 weeks gestation. She had a past medical history significant for morbid obesity and poorly controlled type 2 diabetes mellitus with a hemoglobin A1C of 10.7. On physical exam, the patient was Postoperatively a chest and abdomino-pelvic computed tomography as well as a brain MRI were performed and showed no evidence of metastases. Weekly paclitaxel was started on post-operative day 7 and was continued for 3 months.
The patient has also completed radiation to the chest wall and nodal areas. Currently, the patient has completed 12 cycles of Paclitaxel and 4 cycles of doxorubicin & cyclophosphamide.
A CT of the chest, abdomen and pelvis was performed and revealed no evidence of disease.
BRCA testing is pending.
Discussion
The care of a pregnant patient with breast cancer involves the utilization of a multidisciplinary team, including a geneticist, obstetrician, maternal-fetal medicine specialist, medical oncologist, surgical oncologist and neonatologist. Early ultrasound dating should be obtained in order to provide adequate counseling regarding pregnancy management. In addition, a detailed fetal anatomic evaluation during the mid second trimester is recommended to exclude pre-existing fetal anomalies [4] . The safest interval for most cancer therapies in pregnancy is the second and third trimesters, avoiding induction of teratogenic risks or miscarriages [4]. If growth restriction or non-reassuring fetal status is discovered, these conditions should be managed according to standard obstetrical guidelines. The timing of delivery should take into account maternal and fetal status as well as need for further chemotherapy and expected perinatal outcome, while the mode of delivery should be determined by standard obstetrical
. Chemotherapy during pregnancy should not be given within 3 weeks of planned delivery in order to avoid problems associated with maternal and fetal myelosuppression [16] [17] [18] . Chemotherapy and radiation may be started immediately following a vaginal delivery and one week after cesarean section [9] . Breastfeeding is contraindicated during treatment with chemotherapy or radiation therapy [9] .
If breast cancer is discovered during pregnancy, diagnostic and staging evaluations can be modified to limit fetal exposure [11] . The search for distant metastases may be performed using ultrasonography and MRI [11] . Mastectomy may be performed without fetal injury or spontaneous abortion [11] . Generally breast surgeons prefer to wait until after the first trimester due to the increased risk of spontaneous abortion associated with first trimester surgical intervention, although women who undergo surgery for breast cancer in the first trimester do not seem to have a higher rate of spontaneous loss compared with the general population [13] . Both mastectomy and breast-conserving surgery with axillary lymph node dissection are surgical options for pregnancy-associated breast cancer [11] . Mastectomy is sometimes preferred for breast cancer in pregnancy since follow-up radiation therapy is typically not required post-operatively.
Isosulfan blue or methylene blue dye lymph node mapping is not recommended in pregnant women because anaphylaxis has been observed [11] . Technetium-based sentinel node identification, however, has been performed safely in pregnancy [11] . Both prospective case-control and cohort studies have reported a 20%-40% decreased risk of breast cancer in premenopausal obese patients compared to normal weight controls [23, [25] [26] [27] . Recently, however, Cecchini et al. reported data taken from the Breast Cancer Prevention
Trial (BCPT) that showed an increased risk of invasive breast cancer was noted in overweight and obese premenopausal patients compared to patients of normal weight [28] . In addition, they found only a slightly increased risk of invasive breast cancer among the overweight and 
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